Augmentation of Macular Pigment Following Supplementation with All Three Macular Carotenoids: An Exploratory Study

REFERENCES

• Bressler NM. Age-related macular degeneration is the leading cause of blindness. JAMA. 2004;291:1900–1901.
   PubMed Web of Science ®Google Scholar
• Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. JAMA. 2003;290:2057–2060.
   PubMed Web of Science ®Google Scholar
• Friedman DS, O′Colmain BJ, Munoz B, et al. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol. 2004;122:564–572.
   PubMed Web of Science ®Google Scholar
• Rein DB, Wittenborn JS, Zhang X, et al. Forecasting age-related macular degeneration through the year 2050: The potential impact of new treatments. Arch Ophthalmol. 2009;127:533–540.
   PubMedGoogle Scholar
• Beatty S, Koh HH, Henson D, et al. The role of oxidative stress in the pathogenesis of age-related macular degeneration. Surv Ophthalmol. 2000;45:115–134.
   PubMed Web of Science ®Google Scholar
• Wu J, Seregard S, Algvere PV. Photochemical damage of the retina. Surv Ophthalmol. 2006;51:461–481.
   PubMed Web of Science ®Google Scholar
• Loane E, Kelliher C, Beatty S, et al. The rationale and evidence base for a protective role of macular pigment in age-related maculopathy. Br J Ophthalmol. 2008;92:1163–1168.
   PubMed Web of Science ®Google Scholar
• Bone RA, Landrum JT, Hime GW, et al. Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci. 1993;34:2033–2040.
   PubMed Web of Science ®Google Scholar
• Bone RA, Landrum JT, Tarsis SL. Preliminary identification of the human macular pigment. Vision Res. 1985;25:1531–1535.
   PubMed Web of Science ®Google Scholar
• Snodderly DM, Brown PK, Delori FC, et al. Macular Pigment. 1. Absorbance spectra, localization, and discrimination from other yellow pigments in primate retinas. Invest Ophthalmol Vis Sci. 1984;25:660–673.
   PubMed Web of Science ®Google Scholar
• Sujak A, Gabrielska J, Grudzinski W, et al. Lutein and zeaxanthin as protectors of lipid membranes against oxidative damage: The structural aspects. Arch Biochem Biophys. 1999;371:301–307.
   PubMed Web of Science ®Google Scholar
• Snodderly DM, Auran JD, Delori FC. The macular pigment. II. Spatial distribution in primate retinas. Invest Ophthalmol Vis Sci. 1984;25:674–685.
   PubMed Web of Science ®Google Scholar
• Junghans A, Sies H, Stahl W. Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch Biochem Biophys. 2001;391:160–164.
   PubMed Web of Science ®Google Scholar
• Stringham JM, Hammond BR, Wooten BR, et al. Compensation for light loss resulting from filtering by macular pigment: Relation to the S-cone pathway. Optom Vis Sci. 2006;83:887–894.
   Google Scholar
• Siems WG, Sommerburg O, van Kuijk FJ. Lycopene and beta-carotene decompose more rapidly than lutein and zeaxanthin upon exposure to various pro-oxidants in vitro. Biofactors. 1999;10:105–113.
   PubMed Web of Science ®Google Scholar
• Khachik F, Bernstein PS, Garland DL. Identification of lutein and zeaxanthin oxidation products in human and monkey retinas. Invest Ophthalmol Vis Sci. 1997;38:1802–1811.
   PubMed Web of Science ®Google Scholar
• Sommerburg O, Keunen JEE, Bird AC, et al. Fruits and vegetables that are sources for lutein and zeaxanthin: The macular pigment in human eyes. Br J Ophthalmol. 1998;82:907–910.
   PubMed Web of Science ®Google Scholar
• Bone RA, Landrum JT, Friedes LM, et al. Distribution of lutein and zeaxanthin stereoisomers in the human retina. Exp Eye Res. 1997;64:211–218.
   PubMed Web of Science ®Google Scholar
• Johnson EJ, Neuringer M, Russell RM, et al. Nutritional manipulation of primate retinas. III: Effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys. Invest Ophthalmol Vis Sci. 2005;46:692–702.
   PubMed Web of Science ®Google Scholar
• Maoka T, Arai A, Shimizu M, et al. The first isolation of enantiomeric and meso-zeaxanthin in nature. Comp Biochem Physiol B. 1986;83:121–124.
   PubMedGoogle Scholar
• Trieschmann M, Spital G, Lommatzsch A, et al. Macular pigment: Quantitative analysis on autofluorescence images. Grae Arch Clin Exp Ophthalmol. 2003;241:1006–1012.
   PubMed Web of Science ®Google Scholar
• Hammond BR, Johnson EJ, Russell RM, et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci. 1997;38:1795–1801.
   PubMed Web of Science ®Google Scholar
• Landrum JT, Bone RA, Joa H, et al. A one year study of the macular pigment: The effect of 140 days of a lutein supplement. Exp Eye Res. 1997;65:57–62.
   PubMed Web of Science ®Google Scholar
• Trieschmann M, Beatty S, Nolan JM, et al. Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: The LUNA study. Exp Eye Res. 2007;84:718–728.
   PubMed Web of Science ®Google Scholar
• Bone RA, Landrum JT, Cao Y, et al. Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin. Nutr Metab (Lond). 2007;4:12.
   PubMed Web of Science ®Google Scholar
• Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol. 1995;39:367–374.
   PubMed Web of Science ®Google Scholar
• Thurnham DI, Tremel A, Howard AN. A supplementation study in human subjects with a combination of meso-zeaxanthin, (3R,3′R)-zeaxanthin and (3R,3′R,6′R)-lutein. Br J Nutr. 2008;100:1307–1314.
   Google Scholar
• Wooten BR, Hammond BR, Land RI, et al. A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci. 1999;40:2481–2489.
   PubMed Web of Science ®Google Scholar
• Loane E, Stack J, Beatty S, et al. Measurement of macular pigment optical density using two different heterochromatic flicker photometers. Curr Eye Res. 2007;32:555–564.
   PubMed Web of Science ®Google Scholar
• Kirby ML, Galea M, Loane E, et al. Foveal anatomic associations with the secondary peak and the slope of the macular pigment spatial profile. Invest Ophthalmol Vis Sci. 2009;50:1383–1391.
   PubMed Web of Science ®Google Scholar
• Stringham JM, Hammond BR, Nolan JM, et al. The utility of using customized heterochromatic flicker photometry (cHFP) to measure macular pigment in patients with age-related macular degeneration. Exp Eye Res. 2008;87:445–453.
   PubMed Web of Science ®Google Scholar
• Falsini B, Fadda A, Iarossi G, et al. Retinal sensitivity to flicker modulation: Reduced by early age-related maculopathy. Invest Ophthalmol Vis Sci. 2000;41:1498–1506.
   Web of Science ®Google Scholar
• Tyler CW. Two processes control variations in flicker sensitivity over the life span. J Opt Soc Am A. 1989;6:481–490.
   Google Scholar
• Bone RA, Landrum JT, Gibert JC. Macular pigment and the edge hypothesis of flicker photometry. Vision Res. 2004;44:3045–3051.
   PubMedGoogle Scholar
• Delori FC, Goger DG, Keilhauer C, et al. Bimodal spatial distribution of macular pigment: Evidence of a gender relationship. J Opt Soc Am A Opt Image Sci Vis. 2006;23:521–538.
   PubMed Web of Science ®Google Scholar
• Hammond BR, Wooten BR, Snodderly DM. Individual variations in the spatial profile of human macular pigment. J Opt Soc Am A Opt Image Sci Vis. 1997;14:1187–1196.
   PubMed Web of Science ®Google Scholar
• Berendschot TTJM, van Norren D. Macular pigment shows ringlike structures. Invest Ophthalmol Vis Sci. 2006;47:709–714.
   Google Scholar
• Nolan JM, Stringham JM, Beatty S, et al. Spatial profile of macular pigment and its relationship to foveal architecture. Invest Ophthalmol Vis Sci. 2008;49:2134–2142.
   PubMedGoogle Scholar
• Berendschot TTJM, Goldbohm RA, Klopping WAA, et al. Influence of lutein supplementation on macular pigment, assessed with two objective techniques. Invest Ophthalmol Vis Sci. 2000;41:3322–3326.
   PubMed Web of Science ®Google Scholar
• Johnson EJ, Hammond BR, Yeum KJ, et al. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr. 2000;71:1555–1562.
   PubMed Web of Science ®Google Scholar
• Aleman TS, Duncan JL, Bieber ML, et al. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Invest Ophthalmol Vis Sci. 2001;42:1873–1881.
   PubMed Web of Science ®Google Scholar
• Koh HH, Murray IJ, Nolan D, et al. Serum and macular responses to lutein supplement in subjects with and without age-related maculopathy: A pilot study. Exp Eye Res. 2004;79:21–27.
   PubMed Web of Science ®Google Scholar
• Schalch W, Cohn W, Barker FM, et al. Xanthophyll accumulation in the human retina during supplementation with lutein or zeaxanthin—The LUXEA (LUtein Xanthophyll Eye Accumulation) study. Arch Biochem Biophys. 2007;458:128–135.
   PubMed Web of Science ®Google Scholar
• Wenzel AJ, Sheehan JP, Gerweck C, et al. Macular pigment optical density at four retinal loci during 120 days of lutein supplementation. Ophthalmic Physiol Opt. 2007;27:329–335.
   Google Scholar
• Rodriguez-Carmona M, Kvansakul J, Harlow JA, et al. The effects of supplementation with lutein and/or zeaxanthin on human macular pigment density and color vision. Ophthalmic Physiol Opt. 2006;26:137–147.
   PubMed Web of Science ®Google Scholar
• Burke JD, Curran-Celentano J, Wenzel AJ. Diet and serum carotenoid concentrations affect macular pigment optical density in adults 45 years and older. J Nutr. 2005;135:1208–1214.
   PubMed Web of Science ®Google Scholar
• Johnson EJ, Chung HY, Caldarella SM, et al. The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation. Am J Clin Nutr. 2008;87:1521–1529.
   PubMed Web of Science ®Google Scholar
• Khachik F, de Moura FF, Chew EY, et al. The effect of lutein and zeaxanthin supplementation on metabolites of these carotenoids in the serum of persons aged 60 or older. Invest Ophthalmol Vis Sci. 2006;47:5234–5242.
   PubMed Web of Science ®Google Scholar
• Curran-Celentano J, Hammond BR, Ciulla TA, et al. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr.2001;74:796–802.
   PubMed Web of Science ®Google Scholar
• Richer S, Devenport J, Lang JC. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls. Optometry. 2007;78:213–219.
   PubMedGoogle Scholar
• Bone RA, Landrum JT, Guerra LH, et al. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr. 2003;133:992–998.
   PubMed Web of Science ®Google Scholar
• Bernstein PS, Zhao DY, Sharifzadeh M, et al. Resonance Raman measurement of macular carotenoids in the living human eye. Arch Biochem Biophys. 2004;430:163–169.
   PubMed Web of Science ®Google Scholar
• Thurnham DI. Macular zeaxanthins and lutein—A review of dietary sources and bioavailability and some relationships with macular pigment optical density and age-related macular disease. Nutr Res Rev. 2007;20:163–179.
   PubMed Web of Science ®Google Scholar
• Bhosale P, Larson AJ, Frederick JM, et al. Identification and characterization of a pi isoform of glutathione S-transferase (GSTP1) as a zeaxanthin-binding protein in the macula of the human eye. J Biol Chem. 2004;279:49447–49454.
   PubMed Web of Science ®Google Scholar
• Bernstein PS, Khachik F, Carvalho LS, et al. Identification and quantitation of carotenoids and their metabolites in the tissues of the human eye. Exp Eye Res. 2001;72:215–223.
   PubMed Web of Science ®Google Scholar